Literature DB >> 30528856

Developmental Changes in EEG Phenotypes in a Mouse Model of Fragile X Syndrome.

Teresa H Wen1, Jonathan W Lovelace2, Iryna M Ethell3, Devin K Binder3, Khaleel A Razak4.   

Abstract

Fragile X Syndrome (FXS) is a leading genetic cause of autism and intellectual disabilities. Sensory-processing deficits are common in humans with FXS and an animal model, the Fmr1 knockout (KO) mouse, manifesting in the auditory system as debilitating hypersensitivity and abnormal electroencephalographic (EEG) and event-related potential (ERP) phenotypes. FXS is a neurodevelopmental disorder, but how EEG/ERP phenotypes change during development is unclear. Therefore, we characterized baseline and stimulus-evoked EEG in auditory and frontal cortex of developing (postnatal day (P) 21 and P30) and adult (P60) wildtype (WT) and Fmr1 KO mice with the FVB genetic background. We found that baseline gamma-band power and N1 amplitude of auditory ERP were increased in frontal cortex of Fmr1 KO mice during development and in adults. Baseline gamma power was increased in auditory cortex at P30. Genotype differences in stimulus-evoked gamma power were present in both cortical regions, but the direction and strength of the changes were age-dependent. These findings suggest that cortical deficits are present during early development and may contribute to sensory-processing deficits in FXS, which in turn may lead to anxiety and delayed language. Developmental changes in EEG measures indicate that observations at a single time-point during development are not reflective of FXS disease progression and highlight the need to identify developmental trajectories and optimal windows for treatment.
Copyright © 2018 IBRO. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  EEG; Fragile X Syndrome; gamma oscillations; neurodevelopmental disorders; sensory hypersensitivity

Mesh:

Substances:

Year:  2018        PMID: 30528856      PMCID: PMC6331246          DOI: 10.1016/j.neuroscience.2018.11.047

Source DB:  PubMed          Journal:  Neuroscience        ISSN: 0306-4522            Impact factor:   3.590


  84 in total

Review 1.  The temporal binding deficit hypothesis of autism.

Authors:  Jon Brock; Caroline C Brown; Jill Boucher; Gina Rippon
Journal:  Dev Psychopathol       Date:  2002

2.  Tactile spatial attention enhances gamma-band activity in somatosensory cortex and reduces low-frequency activity in parieto-occipital areas.

Authors:  Markus Bauer; Robert Oostenveld; Maarten Peeters; Pascal Fries
Journal:  J Neurosci       Date:  2006-01-11       Impact factor: 6.167

3.  Nonparametric statistical testing of EEG- and MEG-data.

Authors:  Eric Maris; Robert Oostenveld
Journal:  J Neurosci Methods       Date:  2007-04-10       Impact factor: 2.390

Review 4.  Sensitive and critical periods during neurotypical and aberrant neurodevelopment: a framework for neurodevelopmental disorders.

Authors:  R M Meredith
Journal:  Neurosci Biobehav Rev       Date:  2014-12-10       Impact factor: 8.989

5.  Matrix metalloproteinase-9 deletion rescues auditory evoked potential habituation deficit in a mouse model of Fragile X Syndrome.

Authors:  Jonathan W Lovelace; Teresa H Wen; Sarah Reinhard; Mike S Hsu; Harpreet Sidhu; Iryna M Ethell; Devin K Binder; Khaleel A Razak
Journal:  Neurobiol Dis       Date:  2016-02-02       Impact factor: 5.996

6.  Distinct Inhibitory Circuits Orchestrate Cortical beta and gamma Band Oscillations.

Authors:  Guang Chen; Yuan Zhang; Xiang Li; Xiaochen Zhao; Qian Ye; Yingxi Lin; Huizhong W Tao; Malte J Rasch; Xiaohui Zhang
Journal:  Neuron       Date:  2017-12-20       Impact factor: 17.173

7.  Fmr1 knockout mouse has a distinctive strain-specific learning impairment.

Authors:  C Dobkin; A Rabe; R Dumas; A El Idrissi; H Haubenstock; W T Brown
Journal:  Neuroscience       Date:  2000       Impact factor: 3.590

8.  Impaired cognitive discrimination and discoordination of coupled theta-gamma oscillations in Fmr1 knockout mice.

Authors:  Basma Radwan; Dino Dvorak; André A Fenton
Journal:  Neurobiol Dis       Date:  2016-01-12       Impact factor: 5.996

9.  Autism profiles of males with fragile X syndrome.

Authors:  Susan W Harris; David Hessl; Beth Goodlin-Jones; Jessica Ferranti; Susan Bacalman; Ingrid Barbato; Flora Tassone; Paul J Hagerman; Herman Herman; Randi J Hagerman
Journal:  Am J Ment Retard       Date:  2008-11

Review 10.  Sensory Processing Phenotypes in Fragile X Syndrome.

Authors:  Maham Rais; Devin K Binder; Khaleel A Razak; Iryna M Ethell
Journal:  ASN Neuro       Date:  2018 Jan-Dec       Impact factor: 4.146

View more
  20 in total

1.  Vascular contributions to 16p11.2 deletion autism syndrome modeled in mice.

Authors:  Julie Ouellette; Xavier Toussay; Cesar H Comin; Luciano da F Costa; Mirabelle Ho; María Lacalle-Aurioles; Moises Freitas-Andrade; Qing Yan Liu; Sonia Leclerc; Youlian Pan; Ziying Liu; Jean-François Thibodeau; Melissa Yin; Micael Carrier; Cameron J Morse; Peter Van Dyken; Christopher J Bergin; Sylvain Baillet; Christopher R Kennedy; Marie-Ève Tremblay; Yannick D Benoit; William L Stanford; Dylan Burger; Duncan J Stewart; Baptiste Lacoste
Journal:  Nat Neurosci       Date:  2020-07-13       Impact factor: 24.884

2.  (S)-5-(2'-Fluorophenyl)-N,N-dimethyl-1,2,3,4-tetrahydronaphthalen-2-amine, a Serotonin Receptor Modulator, Possesses Anticonvulsant, Prosocial, and Anxiolytic-like Properties in an Fmr1 Knockout Mouse Model of Fragile X Syndrome and Autism Spectrum Disorder.

Authors:  Jessica L Armstrong; Austen B Casey; Tanishka S Saraf; Munmun Mukherjee; Raymond G Booth; Clinton E Canal
Journal:  ACS Pharmacol Transl Sci       Date:  2020-02-21

3.  Abnormal development of auditory responses in the inferior colliculus of a mouse model of Fragile X Syndrome.

Authors:  Anna O Nguyen; Devin K Binder; Iryna M Ethell; Khaleel A Razak
Journal:  J Neurophysiol       Date:  2020-04-22       Impact factor: 2.714

4.  A sound-driven cortical phase-locking change in the Fmr1 KO mouse requires Fmr1 deletion in a subpopulation of brainstem neurons.

Authors:  Andrew J Holley; Aleya Shedd; Anna Boggs; Jonathan Lovelace; Craig Erickson; Christina Gross; Miranda Jankovic; Khaleel Razak; Kimberly Huber; Jay R Gibson
Journal:  Neurobiol Dis       Date:  2022-05-17       Impact factor: 7.046

5.  Development of Neural Response to Novel Sounds in Fragile X Syndrome: Potential Biomarkers.

Authors:  Lauren Ethridge; Andrew Thaliath; Jeremy Kraff; Karan Nijhawan; Elizabeth Berry-Kravis
Journal:  Am J Intellect Dev Disabil       Date:  2020-11-01

6.  Acute pharmacological inhibition of matrix metalloproteinase-9 activity during development restores perineuronal net formation and normalizes auditory processing in Fmr1 KO mice.

Authors:  Patricia S Pirbhoy; Maham Rais; Jonathan W Lovelace; Walker Woodard; Khaleel A Razak; Devin K Binder; Iryna M Ethell
Journal:  J Neurochem       Date:  2020-06-08       Impact factor: 5.372

7.  A single early-life seizure results in long-term behavioral changes in the adult Fmr1 knockout mouse.

Authors:  Samantha L Hodges; Conner D Reynolds; Suzanne O Nolan; Jessica L Huebschman; James T Okoh; Matthew S Binder; Joaquin N Lugo
Journal:  Epilepsy Res       Date:  2019-08-29       Impact factor: 3.045

Review 8.  Mechanisms underlying auditory processing deficits in Fragile X syndrome.

Authors:  Elizabeth A McCullagh; Sarah E Rotschafer; Benjamin D Auerbach; Achim Klug; Leonard K Kaczmarek; Karina S Cramer; Randy J Kulesza; Khaleel A Razak; Jonathan W Lovelace; Yong Lu; Ursula Koch; Yuan Wang
Journal:  FASEB J       Date:  2020-02-10       Impact factor: 5.191

9.  Aged heterozygous Cdkl5 mutant mice exhibit spontaneous epileptic spasms.

Authors:  Patrick J Mulcahey; Sheng Tang; Hajime Takano; Alicia White; Dayana R Davila Portillo; Owen M Kane; Eric D Marsh; Zhaolan Zhou; Douglas A Coulter
Journal:  Exp Neurol       Date:  2020-06-22       Impact factor: 5.620

10.  Evaluation of lorcaserin as an anticonvulsant in juvenile Fmr1 knockout mice.

Authors:  Tanishka S Saraf; Daniel E Felsing; Jessica L Armstrong; Raymond G Booth; Clinton E Canal
Journal:  Epilepsy Res       Date:  2021-05-27       Impact factor: 2.991

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.